Cough Science News
Find all editions of Cough Science News below and get access to the latest cough science developments, publications, and interviews with cough experts.
Find all editions of Cough Science News below and get access to the latest cough science developments, publications, and interviews with cough experts.
This month’s roundup explores placebo effects in RCC trials, the role of interoception in chronic cough, and the cost burden of persistent symptoms, plus insights from Dr. Nadia Giannetti.
New key cough science publications, Actigraph x Hyfe partnership and more
This year marked significant progress in cough monitoring, solidifying cough as a valuable biomarker in diverse therapeutic areas
New findings on refractory chronic cough (RCC), pulmonary tuberculosis, and pulmonary fibrosis. Plus latest white papers by Hyfe.
Cough Science News Oct 1 - new studies on cough-related stress urinary incontinence, COVID-19 detection in vaccinated adults, and the effectiveness of anti-reflux surgery for chronic cough. Plus, expert discussions from Hyfe's Cough Science Forum and the latest on FDA regulations for cough monitoring technologies
Cough Science News Oct 1 - new studies on cough-related stress urinary incontinence, COVID-19 detection in vaccinated adults, and the effectiveness of anti-reflux surgery for chronic cough. Plus, expert discussions from Hyfe's Cough Science Forum and the latest on FDA regulations for cough monitoring technologies
Cough Science News, August 2024 - Explore studies on cough variability, acute cough duration, and the cost burden of chronic cough. Plus, discover the world’s most comprehensive collection of cinematic coughs and upcoming events in cough science
CougH Science News July 2024 - latest in cough science. Insights on cough detection algorithms, pulmonary fibrosis, asthma diagnosis from cough sounds, and more. Plus, watch expert discussions and stay updated on upcoming events
Hyfe Cough Science News, June 2024. Latest research on cough in fibrotic ILD, high-dose inhaled corticosteroids for chronic cough, and family physicians’ approaches to managing chronic cough. Plus, insights from leading researchers and upcoming events
Cough Science News May 2024 - studies on cough monitoring for COVID-19 surveillance, the effectiveness of codeine for chronic cough, factors in refractory cough in IPF, and more. Plus, insights from researchers and upcoming events
Hyfe Cough Science News, March 2024 - insights on chronic cough management in the UK, common triggers in cough hypersensitivity, and a review of treatments for refractory cough. Plus, expert Q&A and upcoming cough science events.
Here’s What’s Inside
Key Takeaway: This study, co-authored by Hyfe, analyzed data from 97 persistent coughers using Hyfe’s consumer smartphone app to assess their ‘Overall Predictability’, i.e. the ability of one day of cough-monitoring to predict other days. For one-third of coughers, Overall Predictability was < 60%. The study also found a positive correlation between cough rates and higher variability.
Why It Matters: The incumbent method of measuring cough in clinical trials uses 24h snapshots of data, and this study suggests that 24h (one day) is not sufficient to assess overall cough trends. If repeated in other studies, these results support the necessity for continuous monitoring over many days.
Key Takeaway: For patients accessing primary or urgent care with chief complaint of cough, the mean duration of cough was 16.4 days. For those with no infection detected, the mean duration was 18.4 days. The duration and severity of cough did not vary greatly by pathogen or type of infection, and the cough tended to be self-limiting.
Why It Matters: The study of 719 patients (of which 443 were followed up until symptoms resolved) suggests that higher patient awareness of the duration and self-limiting nature of virus-related coughs, may help reduce patient requests for antibiotics. It also suggests that a narrow focus on detecting specific respiratory pathogens in outpatients using clinical PCR panels is unlikely to be of much benefit.
Key Takeaways: This study within the UK’s NHS, showed that mean total cost over the 5 years pre-diagnosis was 3x higher for patients diagnosed with RCC/UCC than for a control group matched for age, gender and smoking history.
Why it matters: RCC/UCC typically have a long, time-consuming route to diagnosis, and this study highlights the increased burden on the healthcare system that this causes.
We’re bringing a different type of fun to Cough Science News:
Discover the world’s most comprehensive collection of cinematic coughs and sneezes. Whether it's background coughs, Oscar-winning coughs, or coughs from horror, fantasy, and romance films, you’ll find it all here!
And don’t miss our favorite feature: Name That Cough—can you guess where the cough comes from? Visit Every Movie Cough and test your skills!
